SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures
DAVE 223.63-8.2%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ~digs who wrote (30)2/22/2004 7:44:31 PM
From: ~digs  Read Replies (1) of 7944
 
SDIX @ 4.163 -0.18 -4.06% 37.66K Feb 20

Strategic Diagnostics Inc. develops, manufactures and markets immunoassay and bioluminescence-based test kits for the food safety and water quality markets through its Test Kit segment. Through its former Antibody segment, the Company also provides antibody and immunoreagent research, development and production services. The Company's food safety unit includes tests for a number of conditions common to genetically modified or engineered plants and food. In the area of water quality, Strategic Diagnostics' tests are used to analyze drinking water, industrial process water and waste water. The Company develops, manufactures and markets a set of monoclonal and polyclonal antibody products and services through its former Antibody segment, which is currently known as the Strategic BioSolutions division. For the nine months ended 9/30/03, revenues rose 11% to $19.3M. Net income totaled $810 thousand vs. a loss of $799 thousand. Revenues reflect increased demand for both the pathogen and GM Trait tests. Net income also reflects improved gross margins and lower SG&A expenses.
finance.yahoo.com

daily chart..
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!Ul14!Uk14]&pref=G
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext